ResearchSafety and efficacy of immune checkpoint therapy for the treatment of patients with cardiac metastasis: a multicenter international retrospective study
ResearchCharacterization of HER2-low breast cancer in young women with germline BRCA1/2 pathogenetic variants: Results of a large international retrospective cohort study
ResearchReal-world outcomes of patients with resected stage III melanoma treated with adjuvant therapies
ResearchCurrent and Novel Treatment Options in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer
ResearchCharacteristics and clinical outcomes of breast cancer in young BRCA carriers according to tumor histology
ResearchComparison of real-world outcomes following immunotherapy in recurrent or metastatic head and neck squamous cell carcinoma with outcomes of randomized controlled trials
ResearchSafety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium
ResearchImmunotherapy response in patients with cutaneous squamous cell carcinoma of head and neck with cranial nerve involvement
ResearchToxicity Profile of Chimeric Antigen Receptor T-Cell and Bispecific Antibody Therapies in Multiple Myeloma: Pathogenesis, Prevention and Management
ResearchTumor infiltrating lymphocytes for breast cancer patient stratification and selection of patients likely to respond to checkpoint inhibitor based immunotherapy
ResearchEGFR-mutated advanced lung cancer. Data from a single institution, the Hospital of Leon, in Spain